EYENOVIA INC. - COMMO
0.5002
06-11月-24 14:59:53
15 分の遅延
株式
-0.0076
-1.50%
本日の幅
0.4886 - 0.5200
ISIN
N/A
ソース
NASDAQ
-
08 4 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
03 4 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
18 3 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
13 3 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th
11 3 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility
13 2 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the U.S. and Canada
16 1 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update
13 11 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
Eyenovia to Report Third Quarter 2023 Results on Monday, November 13
06 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
02 11 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
30 10 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia to Present Data on Preservative-Free Microbial Integrity of the Optejet®
09 10 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference
21 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia to Present at Upcoming H.C. Wainwright 25th Annual Global Investment Conference
07 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia Announces $12 Million Registered Direct Offering
24 8 2023 17:47:29 提供 Nasdaq GlobeNewswire
-
16 8 2023 05:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update
10 8 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
Eyenovia to Present at Upcoming H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference
09 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Eyenovia to Report Second Quarter 2023 Results on Thursday, August 10
07 8 2023 07:00:01 提供 Nasdaq GlobeNewswire